Neutral impact of mTOR inhibitors on cardiovascular outcomes after kidney transplantation

Read full text Summarise with VIRAT
Authors: Eulàlia Domingo-Pinent, Judit Cacho, Matthias Arnaldo Cassia, Verónica Torres, Hugo Vergara, Aileen Herceda, Paula Juarez, Ángela González-Rojas, Diana Rodríguez‐Espinosa, Enrique Montagud‐Marrahí, Carolt Arana, Alícia Molina Andújar
+8 more Pedro Ventura‐Aguiar, Núria Esforzado, Ignacio Revuelta, José‐Vicente Torregrosa, Frederic Oppenheimer, Antonio Francino, Fritz Diekmann, David Cucchiari
Cited by: 0
References: 21

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

ABSTRACT Background In kidney transplantation, it remains unclear whether mammalian target of rapamycin inhibitors (mTORi) improve cardiovascular outcomes—through plaque stabilization and attenuation of left ventricular remodeling—or worsen them by deranging glucose and lipid metabolism. We aimed to assess the true impact of this drug class on major cardiovascular outcomes in a deeply phenotyped cohort with long-term follow-up. Materials and methods All patients transplanted at our center between 1st June 2013 and 31st December 2019 (n = 845) were screened for inclusion. A total of 492 patients were selected through 1:1 propensity score matching (PSM) based on 18 key donor and recipient variables. All patients received tacrolimus (TAC), steroids, and either mTORi (n = 246) or mycophenolic acid (MPA) (n = 246). The primary outcome was major adverse cardiovascular events (MACE), defined as non-fatal myocardial infarction, non-fatal stroke, or cardiovascular death. Results Baseline variables were adequately balanced after PSM (absolute standardized difference

Fields of Study & Subjects

Renal Transplantation Outcomes and Treatments Transplantation: Methods and Outcomes Renal and Vascular Pathologies

Publication details

Journal / source
Clinical Kidney Journal
Volume
19
Issue
4
Pages
sfag101–sfag101
Publication date
25 March 2026
Language
EN